Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Health Care 101: Key Challenges In The Debate
Several news organizations had explainers detailing the ongoing the health reform debate. Buy arimidex to treat cancer.

Peregrine Pharmaceuticals Reports Progress In Cotara(R) Brain Cancer Clinical Program
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, provided an update on progress in the company"s clinical program for Cotara(R), a targeted monoclonal antibody-based therapy being tested in a Phase II trial as a potential new treatment for recurrent glioblastoma multiforme (GBM), a deadly form of brain cancer. The company also reported that patient enrollment in the final cohort of a second Cotara GBM trial, a dose confirmation and dosimetry study, is nearing completion and that interim data from this trial has been accepted for an oral presentation at the Society of Nuclear Medicine Annual Meeting to be held June 13-18, 2009.

generic viagra online


News of the day
UNICEF Appeals For Funding To Urgently Assist Displaced Children And Women In Northwest Pakistan
UNICEF has appealed for an additional $41.4 million to provide urgent assistance to people displaced by fighting in northwest Pakistan. Over half of the displaced are children. UNICEF Pakistan has now almost exhausted its contingency stocks of supplies and funding.
Oncology

Study: Breastfeeding May Reduce Likelihood Of Postpartum MS Attacks

Annette Langer-Gould, MD, PhD (Stanford University) and colleagues followed 32 pregnant women with MS, assessing their disease and breastfeeding status at intervals out to 12 months after giving birth. They found that women who breastfed their babies exclusively (without giving supplemental bottles) for at least the first two months post-partum were less likely to have an MS relapse than those who did not breastfeed or who did not breastfeed exclusively during the first two months (36% who breastfed exclusively experienced a relapse, as compared to 87% who did not breastfeed or who supplemented with formula). This pilot study, funded largely by the National Institutes of Health, was presented at the 2009 American Academy of Neurology meeting and was published early online in the Archives of Neurology on June 8, 2009. While the study is small, it focuses attention on a quandary facing women with MS and their doctors: the crucial time period after giving birth, when there is a higher risk for relapse, and many women are advised to go back on their disease-modifying therapies as soon as possible. Since there is insufficient evidence to support the safety of breastfeeding while using any of these therapies, most babies born to moms with MS are bottle fed, despite known health benefits of breastfeeding for infants. More research is needed to help guide postpartum treatment decisions. Read more about pregnancy and reproductive issues in MS National Multiple Sclerosis Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009